Literature DB >> 27030765

Deficiency of the Survival of Motor Neuron Protein Impairs mRNA Localization and Local Translation in the Growth Cone of Motor Neurons.

Claudia Fallini1, Paul G Donlin-Asp1, Jeremy P Rouanet1, Gary J Bassell2, Wilfried Rossoll3.   

Abstract

Spinal muscular atrophy (SMA) is a neurodegenerative disease primarily affecting spinal motor neurons. It is caused by reduced levels of the survival of motor neuron (SMN) protein, which plays an essential role in the biogenesis of spliceosomal small nuclear ribonucleoproteins in all tissues. The etiology of the specific defects in the motor circuitry in SMA is still unclear, but SMN has also been implicated in mediating the axonal localization of mRNA-protein complexes, which may contribute to the axonal degeneration observed in SMA. Here, we report that SMN deficiency severely disrupts local protein synthesis within neuronal growth cones. We also identify the cytoskeleton-associated growth-associated protein 43 (GAP43) mRNA as a new target of SMN and show that motor neurons from SMA mouse models have reduced levels ofGAP43mRNA and protein in axons and growth cones. Importantly, overexpression of two mRNA-binding proteins, HuD and IMP1, restoresGAP43mRNA and protein levels in growth cones and rescues axon outgrowth defects in SMA neurons. These findings demonstrate that SMN plays an important role in the localization and local translation of mRNAs with important axonal functions and suggest that disruption of this function may contribute to the axonal defects observed in SMA. SIGNIFICANCE STATEMENT: The motor neuron disease spinal muscular atrophy (SMA) is caused by reduced levels of the survival of motor neuron (SMN) protein, which plays a key role in assembling RNA/protein complexes that are essential for mRNA splicing. It remains unclear whether defects in this well characterized housekeeping function cause the specific degeneration of spinal motor neurons observed in SMA. Here, we describe an additional role of SMN in regulating the axonal localization and local translation of the mRNA encoding growth-associated protein 43 (GAP43). This study supports a model whereby SMN deficiency impedes transport and local translation of mRNAs important for neurite outgrowth and stabilization, thus contributing to axon degeneration, muscle denervation, and motor neuron cell death in SMA.
Copyright © 2016 the authors 0270-6474/16/363811-10$15.00/0.

Entities:  

Keywords:  GAP43; RNA trafficking; SMA; SMN; local translation; motor neuron

Mesh:

Substances:

Year:  2016        PMID: 27030765      PMCID: PMC4812137          DOI: 10.1523/JNEUROSCI.2396-15.2016

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  61 in total

Review 1.  The SMN complex.

Authors:  Amelie K Gubitz; Wenqin Feng; Gideon Dreyfuss
Journal:  Exp Cell Res       Date:  2004-05-15       Impact factor: 3.905

2.  GAP-43 mRNA in growth cones is associated with HuD and ribosomes.

Authors:  Catherine L Smith; Rownak Afroz; Gary J Bassell; Henry M Furneaux; Nora I Perrone-Bizzozero; Richard W Burry
Journal:  J Neurobiol       Date:  2004-11

Review 3.  The growth cone cytoskeleton in axon outgrowth and guidance.

Authors:  Erik W Dent; Stephanie L Gupton; Frank B Gertler
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-03-01       Impact factor: 10.005

Review 4.  Spinal muscular atrophy: the role of SMN in axonal mRNA regulation.

Authors:  Claudia Fallini; Gary J Bassell; Wilfried Rossoll
Journal:  Brain Res       Date:  2012-01-28       Impact factor: 3.252

5.  The survival of motor neuron (SMN) protein interacts with the mRNA-binding protein HuD and regulates localization of poly(A) mRNA in primary motor neuron axons.

Authors:  Claudia Fallini; Honglai Zhang; Yuehang Su; Vincenzo Silani; Robert H Singer; Wilfried Rossoll; Gary J Bassell
Journal:  J Neurosci       Date:  2011-03-09       Impact factor: 6.167

6.  Reduced levels of survival motor neuron protein leads to aberrant motoneuron growth in a Xenopus model of muscular atrophy.

Authors:  Qods Ymlahi-Ouazzani; Odile J Bronchain; Elodie Paillard; Chantal Ballagny; Albert Chesneau; Aurélie Jadaud; André Mazabraud; Nicolas Pollet
Journal:  Neurogenetics       Date:  2009-06-11       Impact factor: 2.660

7.  Spinal muscular atrophy and a model for survival of motor neuron protein function in axonal ribonucleoprotein complexes.

Authors:  Wilfried Rossoll; Gary J Bassell
Journal:  Results Probl Cell Differ       Date:  2009

8.  In vivo single branch axotomy induces GAP-43-dependent sprouting and synaptic remodeling in cerebellar cortex.

Authors:  Anna Letizia Allegra Mascaro; Paolo Cesare; Leonardo Sacconi; Giorgio Grasselli; Georgia Mandolesi; Bohumil Maco; Graham W Knott; Lieven Huang; Vincenzo De Paola; Piergiorgio Strata; Francesco S Pavone
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-10       Impact factor: 11.205

Review 9.  Chaperoning ribonucleoprotein biogenesis in health and disease.

Authors:  Livio Pellizzoni
Journal:  EMBO Rep       Date:  2007-04       Impact factor: 8.807

10.  Genome-wide identification of mRNAs associated with the protein SMN whose depletion decreases their axonal localization.

Authors:  Florence Rage; Nawal Boulisfane; Khalil Rihan; Henry Neel; Thierry Gostan; Edouard Bertrand; Rémy Bordonné; Johann Soret
Journal:  RNA       Date:  2013-10-23       Impact factor: 4.942

View more
  54 in total

1.  The Survival of Motor Neuron Protein Acts as a Molecular Chaperone for mRNP Assembly.

Authors:  Paul G Donlin-Asp; Claudia Fallini; Jazmin Campos; Ching-Chieh Chou; Megan E Merritt; Han C Phan; Gary J Bassell; Wilfried Rossoll
Journal:  Cell Rep       Date:  2017-02-14       Impact factor: 9.423

Review 2.  Expanding Axonal Transcriptome Brings New Functions for Axonally Synthesized Proteins in Health and Disease.

Authors:  Amar N Kar; Seung Joon Lee; Jeffery L Twiss
Journal:  Neuroscientist       Date:  2017-06-08       Impact factor: 7.519

Review 3.  Advances in therapy for spinal muscular atrophy: promises and challenges.

Authors:  Ewout J N Groen; Kevin Talbot; Thomas H Gillingwater
Journal:  Nat Rev Neurol       Date:  2018-02-09       Impact factor: 42.937

Review 4.  Diverse role of survival motor neuron protein.

Authors:  Ravindra N Singh; Matthew D Howell; Eric W Ottesen; Natalia N Singh
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2017-01-15       Impact factor: 4.490

5.  TDP-43 transports ribosomal protein mRNA to regulate axonal local translation in neuronal axons.

Authors:  Seiichi Nagano; Junki Jinno; Rehab F Abdelhamid; Yinshi Jin; Megumi Shibata; Shohei Watanabe; Sachiko Hirokawa; Masatoyo Nishizawa; Kenji Sakimura; Osamu Onodera; Hironori Okada; Takashi Okada; Yuko Saito; Junko Takahashi-Fujigasaki; Shigeo Murayama; Shuji Wakatsuki; Hideki Mochizuki; Toshiyuki Araki
Journal:  Acta Neuropathol       Date:  2020-08-16       Impact factor: 17.088

Review 6.  The functional organization of axonal mRNA transport and translation.

Authors:  Irene Dalla Costa; Courtney N Buchanan; Matthew D Zdradzinski; Pabitra K Sahoo; Terika P Smith; Elizabeth Thames; Amar N Kar; Jeffery L Twiss
Journal:  Nat Rev Neurosci       Date:  2020-12-07       Impact factor: 34.870

Review 7.  mRNP assembly, axonal transport, and local translation in neurodegenerative diseases.

Authors:  Bilal Khalil; Dmytro Morderer; Phillip L Price; Feilin Liu; Wilfried Rossoll
Journal:  Brain Res       Date:  2018-02-17       Impact factor: 3.252

Review 8.  Mechanisms and consequences of subcellular RNA localization across diverse cell types.

Authors:  Krysta L Engel; Ankita Arora; Raeann Goering; Hei-Yong G Lo; J Matthew Taliaferro
Journal:  Traffic       Date:  2020-04-29       Impact factor: 6.215

Review 9.  SMN regulation in SMA and in response to stress: new paradigms and therapeutic possibilities.

Authors:  Catherine E Dominguez; David Cunningham; Dawn S Chandler
Journal:  Hum Genet       Date:  2017-08-29       Impact factor: 4.132

Review 10.  To the end of the line: Axonal mRNA transport and local translation in health and neurodegenerative disease.

Authors:  Christopher J Costa; Dianna E Willis
Journal:  Dev Neurobiol       Date:  2017-11-13       Impact factor: 3.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.